![]() |
|
|
Molecular Pharmacology, Vol 12, 519-535, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics
-Bungarotoxin to
Acetylcholine Receptors in Rat Muscle
1 Department of Pharmacology, Medical Sciences Building, Southampton, SO9 3TU, England
The effects of agonists and antagonists on the rate of binding of iodo-
-bungarotoxin to
rat diaphragm have been measured. Homogenates or detergent extracts of rat diaphragm muscle (usually denervated beforehand) were used so that the time course of
binding would not be affected by diffusion. Noninhibitable binding (measured in the
presence of a high tubocurarine concentration) was subtracted from all binding measurements. Bungarotoxin binding was apparently a bimolecular reaction, with rate
constants of 2 x 106 M-1 min-1 (homogenate) and 5 x 106 M-1 min-1 (solubilized). The
rate constant for binding was reduced in the presence of agonists and antagonists, the
relationship between retardation and inhibitor concentration being that expected for
simple competitive antagonism. The equilibrium constants for antagonists, such as
tubocurarine, derived from these results were close to the values found by null pharmacological methods. The apparent KI values for agonists were similar to the concentrations needed to block neuromuscular transmission. The onset of retardation was slower
with agonists than with antagonists, which suggests that desensitization may be
responsible both for retardation of bungarotoxin binding and for neuromuscular blockade. Similar KI values were found for both homogenates and detergent extracts of
denervated muscle, and similar values were found in homogenates of normal and of
denervated muscle, when tubocurarine or carbachol was used as inhibitor.
Note:
ACKNOWLEDGMENT
We are very grateful to Dr. Z. W. Hall for showing us his work (27, 28) before it was published.
This article has been cited by other articles:
![]() |
I. Wenningmann and J. P. Dilger The Kinetics of Inhibition of Nicotinic Acetylcholine Receptors by (+)-Tubocurarine and Pancuronium Mol. Pharmacol., October 1, 2001; 60(4): 790 - 796. [Abstract] [Full Text] [PDF] |
||||